Literature DB >> 7662094

Targeting cancer with radiolabeled antibodies.

D M Goldenberg1, S M Larson, R A Reisfeld, J Schlom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7662094     DOI： 10.1016/0167-5699(95)80177-4

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  4 in total

1.  An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response.

Authors:  J C Becker; N Varki; S D Gillies; K Furukawa; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

2.  In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green.

Authors:  Mikako Ogawa; Nobuyuki Kosaka; Peter L Choyke; Hisataka Kobayashi
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

3.  Eradication of human hepatic and pulmonary melanoma metastases in SCID mice by antibody-interleukin 2 fusion proteins.

Authors:  J C Becker; J D Pancook; S D Gillies; J Mendelsohn; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

Review 4.  Radiolabeled antibodies in renal cell carcinoma.

Authors:  Alexander B Stillebroer; Egbert Oosterwijk; Wim J G Oyen; Peter F A Mulders; Otto C Boerman
Journal:  Cancer Imaging       Date:  2007-11-19       Impact factor: 3.909
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.